Hot Stocks 9/29/16 September 29, 2016
Below is a list of the hottest stocks in the stock market today. I watch these stocks closely in pre market and then look for good trading opportunities right after the stock market open. If you are looking for more ideas, check out my
stocks to buy 2017 page to see my latest stocks picks. Or, if you are into penny stocks, take a look at my
penny stocks for 2016 article.
Top Stocks Today - 9/29/16 - Pre Market
MGT Capital Investments, Inc. (MGT) - MGT is one of the hottest stocks in 2016, Up over 1,000% -
More.....
Aegerion Pharmaceuticals, Inc. (AEGR) - Aegerion Pharmaceuticals’ JUXTAPID® (lomitapide) Capsules Approved in Japan for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH)
Catabasis Pharmaceuticals, Inc. (CATB) - Sarepta Therapeutics (SRPT) on Thursday morning announced a research partnership with another Cambridge biotech focused on Duchenne muscular dystrophy, which CEO Ed Kaye said may be the first of several such deals. Fresh off the U.S. approval of it's drug, Exondys51, Sarepta (SRPT) said it plans to test that drug in combination with an anti-inflammatory drug being developed at Catabasis Pharmaceuticals (CATB) in mice.
Genocea Biosciences, Inc. (GNCA) - Genocea Biosciences, Inc. (GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced positive results from its ongoing Phase 2b trial evaluating a new Phase 3-ready formulation of GEN-003 for the treatment of genital herpes. The study achieved its primary endpoint, with GEN-003 demonstrating a statistically significant reduction of 40 percent in the rate of viral shedding in the 60 µg per protein / 50 µg of Matrix-M2 dose group compared to both baseline and placebo. The viral shedding rate reduction for this dose was consistent with its performance at the same time point in a prior Phase 2 trial.
Arrowhead Pharmaceuticals, Inc. (ARWR) - Amgen Inc. (AMGN) and Arrowhead Pharmaceuticals Inc. said Thursday they have agreed to two cardiovascular collaborations. Under one agreement, Amgen will receive an exclusive license option to Arrowhead's proprietary subcutaneous RNAi delivery platform. Under a second agreement, Agmen will have an option to a worldwide, exclusive license for a RNAi therapy for an undisclosed genetically validated cardiovascular target.
Vista Gold (VGZ) - VGZ is one of the Top Penny Stocks in 2016, up over 400% -
More.....
Costco (COST) will be delivering earnings September 29, 2016. We will be watching the developments in the
stock picks group.
Other Pre Market Gainers - SHIP REXX
For more hot stocks throughout the trading day, view
Today's Biggest Gainers